Global Human Vaccines Administered Orally Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Vaccines Administered Orally Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Vaccines Administered Orally by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Vaccines Administered Orally by Country/Region, 2017, 2022 & 2028

2.2 Human Vaccines Administered Orally Segment by Type

2.2.1 Rotavirus Vaccine

2.2.2 Cholera Vaccine

2.2.3 Oral Polio Vaccine

2.3 Human Vaccines Administered Orally Sales by Type

2.3.1 Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

2.3.2 Global Human Vaccines Administered Orally Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Vaccines Administered Orally Sale Price by Type (2017-2022)

2.4 Human Vaccines Administered Orally Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Human Vaccines Administered Orally Sales by Application

2.5.1 Global Human Vaccines Administered Orally Sale Market Share by Application (2017-2022)

2.5.2 Global Human Vaccines Administered Orally Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Vaccines Administered Orally Sale Price by Application (2017-2022)

3 Global Human Vaccines Administered Orally by Company

3.1 Global Human Vaccines Administered Orally Breakdown Data by Company

3.1.1 Global Human Vaccines Administered Orally Annual Sales by Company (2020-2022)

3.1.2 Global Human Vaccines Administered Orally Sales Market Share by Company (2020-2022)

3.2 Global Human Vaccines Administered Orally Annual Revenue by Company (2020-2022)

3.2.1 Global Human Vaccines Administered Orally Revenue by Company (2020-2022)

3.2.2 Global Human Vaccines Administered Orally Revenue Market Share by Company (2020-2022)

3.3 Global Human Vaccines Administered Orally Sale Price by Company

3.4 Key Manufacturers Human Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Vaccines Administered Orally Product Location Distribution

3.4.2 Players Human Vaccines Administered Orally Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Vaccines Administered Orally by Geographic Region

4.1 World Historic Human Vaccines Administered Orally Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Vaccines Administered Orally Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Vaccines Administered Orally Annual Revenue by Geographic Region

4.2 World Historic Human Vaccines Administered Orally Market Size by Country/Region (2017-2022)

4.2.1 Global Human Vaccines Administered Orally Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Vaccines Administered Orally Annual Revenue by Country/Region

4.3 Americas Human Vaccines Administered Orally Sales Growth

4.4 APAC Human Vaccines Administered Orally Sales Growth

4.5 Europe Human Vaccines Administered Orally Sales Growth

4.6 Middle East & Africa Human Vaccines Administered Orally Sales Growth

5 Americas

5.1 Americas Human Vaccines Administered Orally Sales by Country

5.1.1 Americas Human Vaccines Administered Orally Sales by Country (2017-2022)

5.1.2 Americas Human Vaccines Administered Orally Revenue by Country (2017-2022)

5.2 Americas Human Vaccines Administered Orally Sales by Type

5.3 Americas Human Vaccines Administered Orally Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Vaccines Administered Orally Sales by Region

6.1.1 APAC Human Vaccines Administered Orally Sales by Region (2017-2022)

6.1.2 APAC Human Vaccines Administered Orally Revenue by Region (2017-2022)

6.2 APAC Human Vaccines Administered Orally Sales by Type

6.3 APAC Human Vaccines Administered Orally Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Vaccines Administered Orally by Country

7.1.1 Europe Human Vaccines Administered Orally Sales by Country (2017-2022)

7.1.2 Europe Human Vaccines Administered Orally Revenue by Country (2017-2022)

7.2 Europe Human Vaccines Administered Orally Sales by Type

7.3 Europe Human Vaccines Administered Orally Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Vaccines Administered Orally by Country

8.1.1 Middle East & Africa Human Vaccines Administered Orally Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Vaccines Administered Orally Sales by Type

8.3 Middle East & Africa Human Vaccines Administered Orally Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Vaccines Administered Orally

10.3 Manufacturing Process Analysis of Human Vaccines Administered Orally

10.4 Industry Chain Structure of Human Vaccines Administered Orally

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Vaccines Administered Orally Distributors

11.3 Human Vaccines Administered Orally Customer

12 World Forecast Review for Human Vaccines Administered Orally by Geographic Region

12.1 Global Human Vaccines Administered Orally Market Size Forecast by Region

12.1.1 Global Human Vaccines Administered Orally Forecast by Region (2023-2028)

12.1.2 Global Human Vaccines Administered Orally Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Vaccines Administered Orally Forecast by Type

12.7 Global Human Vaccines Administered Orally Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Human Vaccines Administered Orally Product Offered

13.1.3 Merck Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Human Vaccines Administered Orally Product Offered

13.2.3 GSK Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Human Vaccines Administered Orally Product Offered

13.3.3 Sanofi Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Lanzhou Institute

13.4.1 Lanzhou Institute Company Information

13.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Offered

13.4.3 Lanzhou Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lanzhou Institute Main Business Overview

13.4.5 Lanzhou Institute Latest Developments

13.5 Serum Institute

13.5.1 Serum Institute Company Information

13.5.2 Serum Institute Human Vaccines Administered Orally Product Offered

13.5.3 Serum Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Serum Institute Main Business Overview

13.5.5 Serum Institute Latest Developments

13.6 Valneva

13.6.1 Valneva Company Information

13.6.2 Valneva Human Vaccines Administered Orally Product Offered

13.6.3 Valneva Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Valneva Main Business Overview

13.6.5 Valneva Latest Developments

13.7 Shanghai United Cell

13.7.1 Shanghai United Cell Company Information

13.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Offered

13.7.3 Shanghai United Cell Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shanghai United Cell Main Business Overview

13.7.5 Shanghai United Cell Latest Developments

13.8 Bibcol

13.8.1 Bibcol Company Information

13.8.2 Bibcol Human Vaccines Administered Orally Product Offered

13.8.3 Bibcol Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bibcol Main Business Overview

13.8.5 Bibcol Latest Developments

13.9 PaxVax

13.9.1 PaxVax Company Information

13.9.2 PaxVax Human Vaccines Administered Orally Product Offered

13.9.3 PaxVax Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 PaxVax Main Business Overview

13.9.5 PaxVax Latest Developments

13.10 Vabiotech

13.10.1 Vabiotech Company Information

13.10.2 Vabiotech Human Vaccines Administered Orally Product Offered

13.10.3 Vabiotech Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Vabiotech Main Business Overview

13.10.5 Vabiotech Latest Developments

13.11 Tiantan Biological

13.11.1 Tiantan Biological Company Information

13.11.2 Tiantan Biological Human Vaccines Administered Orally Product Offered

13.11.3 Tiantan Biological Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Tiantan Biological Main Business Overview

13.11.5 Tiantan Biological Latest Developments

13.12 EuBiologics

13.12.1 EuBiologics Company Information

13.12.2 EuBiologics Human Vaccines Administered Orally Product Offered

13.12.3 EuBiologics Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 EuBiologics Main Business Overview

13.12.5 EuBiologics Latest Developments

13.13 Panacea Biotec Ltd

13.13.1 Panacea Biotec Ltd Company Information

13.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered

13.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Panacea Biotec Ltd Main Business Overview

13.13.5 Panacea Biotec Ltd Latest Developments

13.14 Bio-Med

13.14.1 Bio-Med Company Information

13.14.2 Bio-Med Human Vaccines Administered Orally Product Offered

13.14.3 Bio-Med Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bio-Med Main Business Overview

13.14.5 Bio-Med Latest Developments

13.15 Halfkin Bio-Pharmaceuticals

13.15.1 Halfkin Bio-Pharmaceuticals Company Information

13.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered

13.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview

13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Human Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Vaccines Administered Orally Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rotavirus Vaccine

Table 4. Major Players of Cholera Vaccine

Table 5. Major Players of Oral Polio Vaccine

Table 6. Global Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 7. Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 8. Global Human Vaccines Administered Orally Revenue by Type (2017-2022) & ($ million)

Table 9. Global Human Vaccines Administered Orally Revenue Market Share by Type (2017-2022)

Table 10. Global Human Vaccines Administered Orally Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 12. Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 13. Global Human Vaccines Administered Orally Revenue by Application (2017-2022)

Table 14. Global Human Vaccines Administered Orally Revenue Market Share by Application (2017-2022)

Table 15. Global Human Vaccines Administered Orally Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Human Vaccines Administered Orally Sales by Company (2020-2022) & (K Units)

Table 17. Global Human Vaccines Administered Orally Sales Market Share by Company (2020-2022)

Table 18. Global Human Vaccines Administered Orally Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Human Vaccines Administered Orally Revenue Market Share by Company (2020-2022)

Table 20. Global Human Vaccines Administered Orally Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Human Vaccines Administered Orally Producing Area Distribution and Sales Area

Table 22. Players Human Vaccines Administered Orally Products Offered

Table 23. Human Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Human Vaccines Administered Orally Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Human Vaccines Administered Orally Sales Market Share Geographic Region (2017-2022)

Table 28. Global Human Vaccines Administered Orally Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Human Vaccines Administered Orally Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Human Vaccines Administered Orally Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Human Vaccines Administered Orally Sales Market Share by Country/Region (2017-2022)

Table 32. Global Human Vaccines Administered Orally Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Human Vaccines Administered Orally Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 35. Americas Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 36. Americas Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 38. Americas Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 39. Americas Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 40. Americas Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 41. Americas Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 42. APAC Human Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)

Table 43. APAC Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)

Table 44. APAC Human Vaccines Administered Orally Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Human Vaccines Administered Orally Revenue Market Share by Region (2017-2022)

Table 46. APAC Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 47. APAC Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 48. APAC Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 49. APAC Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 50. Europe Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 51. Europe Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 52. Europe Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 54. Europe Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 55. Europe Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 56. Europe Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 57. Europe Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Human Vaccines Administered Orally

Table 67. Key Market Challenges & Risks of Human Vaccines Administered Orally

Table 68. Key Industry Trends of Human Vaccines Administered Orally

Table 69. Human Vaccines Administered Orally Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Human Vaccines Administered Orally Distributors List

Table 72. Human Vaccines Administered Orally Customer List

Table 73. Global Human Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Human Vaccines Administered Orally Sales Market Forecast by Region

Table 75. Global Human Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Human Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Human Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Human Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Human Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Human Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Human Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Human Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Human Vaccines Administered Orally Product Offered

Table 95. Merck Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. GSK Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 99. GSK Human Vaccines Administered Orally Product Offered

Table 100. GSK Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. GSK Main Business

Table 102. GSK Latest Developments

Table 103. Sanofi Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 104. Sanofi Human Vaccines Administered Orally Product Offered

Table 105. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Sanofi Main Business

Table 107. Sanofi Latest Developments

Table 108. Lanzhou Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 109. Lanzhou Institute Human Vaccines Administered Orally Product Offered

Table 110. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Lanzhou Institute Main Business

Table 112. Lanzhou Institute Latest Developments

Table 113. Serum Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 114. Serum Institute Human Vaccines Administered Orally Product Offered

Table 115. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Serum Institute Main Business

Table 117. Serum Institute Latest Developments

Table 118. Valneva Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 119. Valneva Human Vaccines Administered Orally Product Offered

Table 120. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Valneva Main Business

Table 122. Valneva Latest Developments

Table 123. Shanghai United Cell Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 124. Shanghai United Cell Human Vaccines Administered Orally Product Offered

Table 125. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Shanghai United Cell Main Business

Table 127. Shanghai United Cell Latest Developments

Table 128. Bibcol Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 129. Bibcol Human Vaccines Administered Orally Product Offered

Table 130. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Bibcol Main Business

Table 132. Bibcol Latest Developments

Table 133. PaxVax Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 134. PaxVax Human Vaccines Administered Orally Product Offered

Table 135. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. PaxVax Main Business

Table 137. PaxVax Latest Developments

Table 138. Vabiotech Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 139. Vabiotech Human Vaccines Administered Orally Product Offered

Table 140. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Vabiotech Main Business

Table 142. Vabiotech Latest Developments

Table 143. Tiantan Biological Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 144. Tiantan Biological Human Vaccines Administered Orally Product Offered

Table 145. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Tiantan Biological Main Business

Table 147. Tiantan Biological Latest Developments

Table 148. EuBiologics Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 149. EuBiologics Human Vaccines Administered Orally Product Offered

Table 150. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. EuBiologics Main Business

Table 152. EuBiologics Latest Developments

Table 153. Panacea Biotec Ltd Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 154. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered

Table 155. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Panacea Biotec Ltd Main Business

Table 157. Panacea Biotec Ltd Latest Developments

Table 158. Bio-Med Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 159. Bio-Med Human Vaccines Administered Orally Product Offered

Table 160. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Bio-Med Main Business

Table 162. Bio-Med Latest Developments

Table 163. Halfkin Bio-Pharmaceuticals Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 164. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered

Table 165. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Halfkin Bio-Pharmaceuticals Main Business

Table 167. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Human Vaccines Administered Orally

Figure 2. Human Vaccines Administered Orally Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Vaccines Administered Orally Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Vaccines Administered Orally Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Vaccines Administered Orally Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rotavirus Vaccine

Figure 10. Product Picture of Cholera Vaccine

Figure 11. Product Picture of Oral Polio Vaccine

Figure 12. Global Human Vaccines Administered Orally Sales Market Share by Type in 2021

Figure 13. Global Human Vaccines Administered Orally Revenue Market Share by Type (2017-2022)

Figure 14. Human Vaccines Administered Orally Consumed in Public

Figure 15. Global Human Vaccines Administered Orally Market: Public (2017-2022) & (K Units)

Figure 16. Human Vaccines Administered Orally Consumed in Private

Figure 17. Global Human Vaccines Administered Orally Market: Private (2017-2022) & (K Units)

Figure 18. Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Figure 19. Global Human Vaccines Administered Orally Revenue Market Share by Application in 2021

Figure 20. Human Vaccines Administered Orally Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Human Vaccines Administered Orally Revenue Market Share by Company in 2021

Figure 22. Global Human Vaccines Administered Orally Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Human Vaccines Administered Orally Revenue Market Share by Geographic Region in 2021

Figure 24. Global Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)

Figure 25. Global Human Vaccines Administered Orally Revenue Market Share by Country/Region in 2021

Figure 26. Americas Human Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 27. Americas Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 28. APAC Human Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 29. APAC Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 30. Europe Human Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 31. Europe Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Human Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 34. Americas Human Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 35. Americas Human Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 36. United States Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Human Vaccines Administered Orally Sales Market Share by Region in 2021

Figure 41. APAC Human Vaccines Administered Orally Revenue Market Share by Regions in 2021

Figure 42. China Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Human Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 49. Europe Human Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 50. Germany Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Human Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 57. Egypt Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Human Vaccines Administered Orally in 2021

Figure 63. Manufacturing Process Analysis of Human Vaccines Administered Orally

Figure 64. Industry Chain Structure of Human Vaccines Administered Orally

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles